OKT3 for recipients with steroid-resistant acute rejection after liver transplantation.
- Author:
Lin-Wei WU
1
;
Xiao-Shun HE
;
Xiao-Feng ZHU
;
Dong-Ping WANG
;
Wei-Qiang JU
;
Qiang TAI
;
Jie-Fu HUANG
Author Information
1. Organ Transplantation Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China. lw97002@163.com
- Publication Type:Journal Article
- MeSH:
Adult;
Graft Rejection;
drug therapy;
Humans;
Immunosuppressive Agents;
therapeutic use;
Liver Transplantation;
Male;
Middle Aged;
Muromonab-CD3;
therapeutic use
- From:
Chinese Journal of Hepatology
2007;15(11):857-858
- CountryChina
- Language:Chinese
